Posts

Trump Imposes 100% Tariffs on Imported Patented Drugs with Key Exceptions

US President Trump signed an executive order imposing 100% tariffs on patented pharmaceuticals made abroad unless companies commit to building US plants or secure trade deals 1 2 4 . Large companies have 120 days and smaller ones 180 days to submit reshoring plans, facing 20% tariffs if committed; completion required by end of Trump's term 1 . Exemptions include EU, Japan, South Korea, Switzerland (15% duty), UK (tariff-free for 3 years), and companies with Most Favored Nation pricing deals plus US plants (0% tariff) 1 3 . Generic drugs are not subject to these tariffs, with reassessment in one year 1 . Order announced Thursday, April 3, 2026, alongside metal tariff reforms; officials claim no impact on consumer drug prices 1 . Sources: 1. https://www.ndtv.com/world-news/donald-trump-imposes-100-tariffs-on-foreign-made-drugs-reshapes-metal-duties-11304735 2. https://www.statnews.com/2026/04/01/trump-section-232-tariffs-imported-brand-drugs/ 3. https://www.youtube.co...

Novo Nordisk Launches Discounted Multi-Month Subscription Program for Wegovy via Telehealth Providers

FDA Ties Amgen's Tavneos to Eight Deaths and 76 Liver Injury Cases

Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts

Biotech IPOs Rebound as AI Drives Drug Development Innovation

Palleon Pharmaceuticals to Present on Development of HLX316/E-688 at AACR Annual Meeting

Biodexa Announces Partnership with Syngene to Manufacture MTX240 GMP Clinical Trial Supplies

Trump Announces Up to 100% Tariffs on Imported Patented Drugs

Curve Biosciences Appoints Dr. Amit Singal as Chief Medical Officer

SV Health Investors Acquires EpiVax

UK Finalises US Pharma Trade Deal Securing Tariff-Free Access for British Medicines

Gilead Cancels Midstage HIV Trial as FDA Clinical Hold Remains Intact

Alto Neurosciences Halts ALTO-101 PDE4 Inhibitor Development After Phase 2 Schizophrenia Trial Failure